February 17, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss on March 2 whether to recommend approval of Shionogi’s guanfacine for the treatment of attention deficit hyperactivity disorder (ADHD) in children. The Pharmaceutical Affairs and...read more